A Specific Mechanism of Nonspecific Inhibition
Top Cited Papers
- 22 August 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (20) , 4265-4272
- https://doi.org/10.1021/jm030266r
Abstract
Promiscuous small molecules plague screening libraries and hit lists. Previous work has found that several nonspecific compounds form submicrometer aggregates, and it has been suggested that this aggregate species is responsible for the inhibition of many different enzymes. It is not understood how aggregates inhibit their targets. To address this question, biophysical, kinetic, and microscopy methods were used to study the interaction of promiscuous, aggregate-forming inhibitors with model proteins. By use of centrifugation and gel electrophoresis, aggregates and protein were found to directly interact. This is consistent with a subsequent observation from confocal fluorescence microscopy that aggregates concentrate green fluorescent protein. β-Lactamase mutants with increased or decreased thermodynamic stability relative to wild-type enzyme were equally inhibited by an aggregate-forming compound, suggesting that denaturation by unfolding was not the primary mechanism of interaction. Instead, visualization by electron microscopy revealed that enzyme associates with the surface of inhibitor aggregates. This association could be reversed or prevented by the addition of Triton X-100. These observations suggest that the aggregates formed by promiscuous compounds reversibly sequester enzyme, resulting in apparent inhibition. They also suggest a simple method to identify or reverse the action of aggregate-based inhibitors, which appear to be widespread.Keywords
This publication has 18 references indexed in Scilit:
- Designing screens: how to make your hits a hitNature Reviews Drug Discovery, 2003
- Nanomolar Inhibitors of AmpC β-LactamaseJournal of the American Chemical Society, 2002
- Integration of virtual and high-throughput screeningNature Reviews Drug Discovery, 2002
- Evolution of an Antibiotic Resistance Enzyme Constrained by Stability and Activity Trade-offsJournal of Molecular Biology, 2002
- Development of a Virtual Screening Method for Identification of “Frequent Hitters” in Compound LibrariesJournal of Medicinal Chemistry, 2001
- Improving the Odds in Discriminating “Drug-like” from “Non Drug-like” CompoundsJournal of Chemical Information and Computer Sciences, 2000
- Inhibition of voltage‐dependent sodium channels by Ro 31‐8220, a ‘specific’ protein kinase C inhibitorFEBS Letters, 2000
- Structure-Based Enhancement of Boronic Acid-Based Inhibitors of AmpC β-LactamaseJournal of Medicinal Chemistry, 1998
- Reactive compounds and in vitro false positives in HTSDrug Discovery Today, 1997
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997